A new point-of-care test for the rapid antimicrobial susceptibility assessment of uropathogens
PLOS ONE · 05.07.2023 · 18 (7) · e0284746
DOI: 10.1371/journal.pone.0284746 ↗Kurz gefasst
Klinische Studie in der Zeitschrift PLOS ONE, online erschienen am 05.07.2023. Verfasst von Alyexandra Arienzo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Interuniversity Consortium "Biostructures and Biosystems National Institute" (INBB), Rome, Italy. Hauptthemen laut MEDLINE: Urinary Tract Infections. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Lazio Innova.
Abstract (Originalsprache)
Bacterial resistance to antimicrobials is considered a major issue worldwide. This condition may account for treatment failure of urinary tract infections, which are among the most common infections both in community and healthcare settings. Therapy against uropathogens is generally administered empirically, possibly leading to unsuccessful therapy, recurrence and development of antibiotic resistance. The reduction in analytical time to obtain antimicrobial susceptibility test (AST) results could play a key role in reducing the cost of healthcare, providing information about antibiotic efficacy and thus preventing from either exploiting new and expensive antibiotics unnecessarily or using obsolete and ineffective ones. A more rational choice among treatment options would hence lead to more effective treatment and faster resolution. In this paper we evaluated the performance of a new Point Of Care Test (POCT) for the rapid prediction of antimicrobial susceptibility in urine samples performed without the need of a laboratory or specialized technicians. 349 patients were enrolled in two open-label, monocentric, non-interventional clinical trials in partnership with an Emergency Medicine ward and the Day Hospital of two large healthcare facilities in Rome. Antibiogram was carried out on 97 patients. Results from analysis of urine samples with the POCT were compared with those from routine AST performed on culture-positive samples, displaying high accuracy (>90%) for all tested antimicrobial drugs and yielding reliable results in less than 12 hours from urine collection thus reducing analytical and management costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Interuniversity Consortium "Biostructures and Biosystems National Institute" (INBB), Rome, Italy.
- Department of Science, Roma Tre University, Rome, Italy.
- MBS srl, Rome, Italy.
- Emergency Medicine, Department of Medical-Surgery Sciences and Translational Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
- Istituto Dermopatico dell'Immacolata, Rome, Italy.
ORCID-Profile: Giovanni Antonini
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Lazio Innova
Zitieren
APA
Arienzo, A., Murgia, L., Cellitti, V., Ferrante, V., Stalio, O., Losito, F., Gallo, V., Tomassetti, F., Marino, R., Cristofano, F., Orrù, M., Visca, P., Di Somma, S., Silvestri, L., Ziparo, V., & Antonini, G. (2023). A new point-of-care test for the rapid antimicrobial susceptibility assessment of uropathogens. PLOS ONE, 18(7), e0284746. https://doi.org/10.1371/journal.pone.0284746
Vancouver
Arienzo A, Murgia L, Cellitti V, Ferrante V, Stalio O, Losito F, et al. A new point-of-care test for the rapid antimicrobial susceptibility assessment of uropathogens. PLOS ONE. 2023;18(7):e0284746. doi:10.1371/journal.pone.0284746
BibTeX
@article{Arienzo2023,
author = {Arienzo, Alyexandra and Murgia, Lorenza and Cellitti, Valentina and Ferrante, Valeria and Stalio, Ottavia and Losito, Francesca and Gallo, Valentina and Tomassetti, Federica and Marino, Rossella and Cristofano, Flavia and Orrù, Michela and Visca, Paolo and Di Somma, Salvatore and Silvestri, Lorena and Ziparo, Vincenzo and Antonini, Giovanni},
title = {A new point-of-care test for the rapid antimicrobial susceptibility assessment of uropathogens},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {7},
pages = {e0284746},
doi = {10.1371/journal.pone.0284746}
}
EUVIMED